Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. - Test2 - elhamkhani - TriplyDB

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.

http://www.wikidata.org/entity/Q34138025

about

Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment Corticostriatal Dysfunction in Huntington's Disease: The Basics Danggui-Shaoyao-San: New Hope for Alzheimer's Disease Spontaneous Neuronal Activity in Developing Neocortical Networks: From Single Cells to Large-Scale Interactions Activin Signaling in the Pathogenesis and Therapy of Neuropsychiatric Diseases The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbations Dysfunction of NMDA receptors in Alzheimer's disease Neuroimmune Function and the Consequences of Alcohol Exposure Tissue-type plasminogen activator is a neuroprotectant in the central nervous system Transglutaminase is a therapeutic target for oxidative stress, excitotoxicity and stroke: a new epigenetic kid on the CNS block Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Combotherapy and current concepts as well as future strategies for the treatment of Alzheimer's disease Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum Current understanding of TRPM7 pharmacology and drug development for stroke The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission Cross-talk and regulation between glutamate and GABAB receptors Current approaches to enhance glutamate transporter function and expression Current view on the functional regulation of the neuronal K(+)-Cl(-) cotransporter KCC2 Molecular bases of NMDA receptor subtype-dependent properties The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia Neuropathogenesis of HIV-1-associated neurocognitive disorders: a possible involvement of D-serine Serine racemase: a key player in apoptosis and necrosis Consolidation and translation regulation Synaptic dysfunction and septin protein family members in neurodegenerative diseases Modulation of extrasynaptic NMDA receptors by synaptic and tonic zinc.Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?Striatal-enriched protein tyrosine phosphatase in Alzheimer's disease.Role of NMDA Receptor-Mediated Glutamatergic Signaling in Chronic and Acute Neuropathologies Neuron-Microglia Interactions in Mental Health Disorders: "For Better, and For Worse"Time and space profiling of NMDA receptor co-agonist functions Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss Chlorpyrifos Toxicity in Mouse Cultured Cerebellar Granule Neurons at Different Stages of Development: Additive Effect on Glutamate-Induced Excitotoxicity Development of NMDAR antagonists with reduced neurotoxic side effects: a study on GK11 Impaired novelty acquisition and synaptic plasticity in congenital hyperammonemia caused by hepatic glutamine synthetase deficiency Nuclear translocation of jacob in hippocampal neurons after stimuli inducing long-term potentiation but not long-term depression

P2860

Q24632936-1E40B6BA-4828-4A5D-89C6-E5725D5E2564 Q24633004-2205508B-F9DC-4430-B551-9968774531E2 Q26738379-B5EB4534-F151-440C-A508-ECA793E1D0B2 Q26738897-55389274-D61E-4D99-AE14-3D2A8782B311 Q26744099-554F21A7-6808-4FFF-AF65-BB2777075C5A Q26744752-757487B9-8BC4-4DD9-9CCB-B4FD840713BA Q26750778-D5162094-2AC2-4E65-936A-9D4F11F45EB8 Q26765956-E43922DC-87EB-4217-838E-4950C8FFA077 Q26766185-0B8A11FA-0131-4A7D-83A3-0C406BEAEEFD Q26773207-035A81D3-2070-49D1-B0CE-01704E09F77B Q26782904-96C4746A-066E-4E54-8039-8EEC0CC3F9CE Q26824549-F3DE1A27-C3D3-401D-9631-6EC7D84C14CD Q26829556-6767731E-8A7A-4F79-8372-60EA4FE476A1 Q26829899-6D6D4738-440B-4D3A-A9D1-92B15C0C7F81 Q26830533-EAE68B74-093A-4866-A645-5A94A6CEF05C Q26852967-7AA3BB1A-9B0C-421E-8403-22E471771C74 Q26853706-073ED08F-9CEA-4FE3-B8B9-902B83A67CCF Q26859198-A6DEB8EC-5159-4633-BBDF-539B319758A6 Q26861100-B1CBAA30-6E52-4DC9-8683-74B8E0CF3E86 Q26996723-DA2A8C13-059E-462B-8366-A133646EE644 Q27004031-C53F6DCA-28A0-4324-83D7-F6469EA20B9B Q27012689-DEC57C2D-672E-43A3-808F-0C403E1A9F99 Q27023087-57DD3B2A-01E8-486F-8F8C-D78E7ED25DCA Q27024914-8C2C39BF-096F-4F38-84A5-442A5B492290 Q27025560-A978B345-835F-4E49-A9DA-CEE07AD4F693 Q27025904-AC69A24A-79AD-4CEF-A01F-72CBAD690BA8 Q27026829-231D0C6D-E893-4532-B192-4F16F3DC034F Q27324069-17361EF6-4731-4897-AA89-9289670FB537 Q27324133-EC52CC68-A33C-4828-AB83-A097CC2F5252 Q27687325-E0668D98-8BC6-413F-8E06-5938FE2817EC Q28072353-BEFDD82E-FC4C-4199-91DD-6901E23EF724 Q28076010-0239DE42-265A-43DF-9C89-C3CCFA0BD6B8 Q28084245-09AB81EF-BFBA-46C4-8452-1B7139185930 Q28265056-4795EDB0-4372-41BD-9D55-1EDB84FAB9E9 Q28270699-B2779F3D-1B06-488F-BCC3-6F8F2F40F68E Q28293023-620A4EEE-FA28-4A74-AEF5-193B1A911E1F Q28388628-8F555E5B-E084-4045-892E-76B9B46FF809 Q28391272-4E61898B-E5C8-4CBA-B824-2FA8CF260906 Q28397860-942C2365-31E6-48EE-A7E9-1AF17919E9EC Q28477205-F2032905-9BA1-4CB4-AF31-E0247DDB9532

P2860

Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.

http://www.wikidata.org/entity/Q34138025

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Synaptic versus extrasynaptic ...... r neurodegenerative disorders.

@ast

Synaptic versus extrasynaptic ...... r neurodegenerative disorders.

@en

Synaptic versus extrasynaptic ...... r neurodegenerative disorders.

@nl

type

label

Synaptic versus extrasynaptic ...... r neurodegenerative disorders.

@ast

Synaptic versus extrasynaptic ...... r neurodegenerative disorders.

@en

Synaptic versus extrasynaptic ...... r neurodegenerative disorders.

@nl

prefLabel

Synaptic versus extrasynaptic ...... r neurodegenerative disorders.

@ast

Synaptic versus extrasynaptic ...... r neurodegenerative disorders.

@en

Synaptic versus extrasynaptic ...... r neurodegenerative disorders.

@nl

P1433

Q34138025-69B94EAA-7613-4517-9C2D-461B0E1DC17B

P1476

Q34138025-E7B85A91-020E-4390-8084-92D4DC117E0A

P2093

Q34138025-87A8919D-EFB6-4C91-95D5-10B247722318

P2860

Q34138025-01547617-CF78-491F-98FC-97AD1E604B4F

Q34138025-03154CCA-9B1C-4B27-A6AF-7086E3DDB9FD

Q34138025-065A8DD5-F782-4C54-9BF6-D87BB7E11481

Q34138025-07602F04-FAD3-40B2-9FB4-4606BFDFB448

Q34138025-0BE8E58E-822A-45AE-B2D4-7D3AE0A7D506

Q34138025-0F0C4F05-9686-4CF6-ABF8-FD59CE9891C5

Q34138025-141C5905-F138-48A5-BF4C-2BFED0B38A6D

Q34138025-15E3BC6D-F10C-44DF-9D88-91504A85B815

Q34138025-16593299-8986-4A1F-9F4B-3DB476C3BC5A

Q34138025-16DD0A7C-A55F-4092-AA7B-FDF77EE0ECD9

P2888

Q34138025-AFE51E60-6E55-46FA-A6E5-AB5E43F77F82

P304

Q34138025-78A18131-A04A-40F8-8A98-B21D522FB4F4

P31

Q34138025-3109993D-2D27-4BC1-846E-E1AEEE0EB078

P356

Q34138025-34A0316C-7AF5-4554-A1C4-61F143B513A8

P407

Q34138025-C0874D6D-6F39-49EE-83F0-C4F6A563F5A5

P433

Q34138025-90A675D4-002B-42AF-8A3F-F5B6E0A41C45

P478

Q34138025-2723CDFE-9CB3-44D4-83F3-2945B4E25910

P50

Q34138025-7351FB53-B0FE-4540-B438-FB2799ACD129

P577

Q34138025-4D931BF0-D7E8-4DF3-BBC5-8B2058FBA352

P5875

Q34138025-71E55841-7DA1-4B83-8036-105CE69CA9D3

P6179

Q34138025-4719A27F-F7BE-4534-BC5D-6749119DF0A8

P698

Q34138025-E5333C71-09D5-4EDC-9CB9-1EA9B4E5EB17

P921

Q34138025-9530ED01-F636-43E9-A227-E6FA04035A6F

P932

Q34138025-0C9407E8-53D2-4F09-9B5C-BDCDDADAB7EC

P356

P1433

Nature Reviews Neuroscience

P1476

Synaptic versus extrasynaptic ...... r neurodegenerative disorders.

@en

P2093

Hilmar Bading

http://www.w3.org/2001/XMLSchema#string

P2860

A synaptic model of memory: long-term potentiation in the hippocampus

Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression

Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine

Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity

Nuclear protein CBP is a coactivator for the transcription factor CREB

A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span

Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses

TORC1 is a calcium- and cAMP-sensitive coincidence detector involved in hippocampal long-term synaptic plasticity

ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin.

Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD

P2888

P304

682-696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRN2911

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Giles E. Hardingham

P577

2010-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46273909

http://www.w3.org/2001/XMLSchema#string

P6179

1043587107

http://www.w3.org/2001/XMLSchema#string

P698

20842175

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

2948541

http://www.w3.org/2001/XMLSchema#string